FRONTLINE LOW-INTENSITY VAH ACHIEVES HIGH MRD-NEGATIVE REMISSION RATES IN YOUNGER PATIENTS WITH NEWLY DIAGNOSED AML

Venclexta (venetoclax) - Roche, AbbVie

Synribo (omacetaxine mepesuccinate) - Teva

azacitidine - Generic mfg.

Yannan Jia 1; Jun Yang 1; Xinxin Xia 1; Yu Cai 1; Yin Tong 1; Baoxia Dong 1; Xianmin Song1

May 12, 2026